Back to School: How biopharma can reboot drug development. Access exclusive analysis here

RThrombin regulatory update

King Pharmaceuticals Inc. (KG, Bristol, Tenn.) said it submitted a Citizen's Petition to FDA asserting that ZGEN has not provided the agency

Read the full 231 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE